GI
RIGL icon

Gradient Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Gradient Investments’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30
Closed – – 1632
2022
Q3 		$0 Hold
30
– – ﹤0.01% 1509
2022
Q2 		$0 Hold
30
– – ﹤0.01% 1353
2022
Q1 		$1K Hold
30
– – ﹤0.01% 1121
2021
Q4 		$1K Hold
30
– – ﹤0.01% 1176
2021
Q3 		$1K Hold
30
– – ﹤0.01% 1098
2021
Q2 		$1K Hold
30
– – ﹤0.01% 1100
2021
Q1 		$1K Buy
+30
New +$1.19K ﹤0.01% 1102

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gradient Investments's RIGL Position: Q4 2022 in Review

Gradient Investments sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 30 shares.

Gradient Investments first reported a position in RIGL in Q1 2021 and held it in 7 quarters. The position peaked at $1K in Q1 2022. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

  • Gradient Investments reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Gradient Investments sold 30 Rigel Pharmaceuticals shares in Q4 2022.
  • Gradient Investments first reported a position in Rigel Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Gradient Investments's Rigel Pharmaceuticals position peaked at $1K in Q1 2022.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Gradient Investments's 13F filing for Q4 2022, filed 10 Jan 2023.